Medical Device & IVD Clinical Evidence Across Europe
Bioexcel supports medical device and IVD manufacturers with European clinical investigations, PMCF, retrospective studies, IVD clinical performance programs, site feasibility, monitoring, data management, biostatistics and regulatory evidence generation.
Our model combines suitable European clinical and operational resources with centralized Bioexcel clinical, data, statistical and regulatory expertise.
Does Bioexcel Support Medical Device Clinical Studies in Europe?
Yes. Bioexcel supports European medical device and IVD clinical evidence programs through suitable local clinical resources combined with centralized project management, data management, biostatistics, medical writing and regulatory evidence support.
Bioexcel Lifesciences & Research LLP is a specialized medical device and IVD clinical research organization supporting European clinical evidence programs through suitable local sites and operational resources combined with centralized clinical strategy, project management, data management, biostatistics and regulatory documentation.
A European Site Is Only One Part of the Evidence Program
A successful European clinical program requires alignment across:
- Country selection
- Regulatory strategy
- Ethics pathway
- Patient or specimen availability
- Investigator experience
- Clinical practice
- Data protection
- Contracts
- Monitoring
- Data management
- Statistics
- Final regulatory evidence
Bioexcel helps sponsors connect the local study with the ultimate EU MDR or EU IVDR evidence objective.
From Sponsor Requirement to European Clinical Evidence
Regulatory & Evidence Strategy
- Device / IVD
- Intended purpose
- Target market
- Evidence gap
- Study type
- Regulatory objective
Output: European Evidence Strategy
Country Feasibility
- Patient / specimen availability
- Clinical practice
- Investigator expertise
- Ethics / regulatory considerations
- Timeline
- Cost
- Language
- Study suitability
Output: Country Recommendation
Site & Investigator Feasibility
- Patient population
- Device experience
- Research experience
- Infrastructure
- Recruitment
- Reference laboratory capability
Output: Shortlisted Sites
Start-Up
- Site documents
- Ethics
- Applicable regulatory submissions
- Contracts
- Budgets
- Training
- Site initiation
Output: Activated Site(s)
Local Clinical Execution
- Recruitment
- Clinical procedures
- Sample collection
- Study coordination
- Monitoring
- Safety
- Protocol compliance
Output: European Clinical Data
Central Data & Biometrics
- eCRF / EDC
- Data management
- Query management
- Database lock
- Biostatistics
Output: Analysis-Ready Dataset
Regulatory Evidence
- CIR
- CPSR
- PMCF Evaluation Report
- CER
- PER
- Regulatory responses
Output: Submission-Ready Evidence
What European Clinical Services Does Bioexcel Provide?
Bioexcel supports European site feasibility, investigator identification, clinical investigations, PMCF, retrospective PMCF, IVD performance studies, layperson studies, monitoring, data management, biostatistics, medical writing and regulatory evidence integration.
What European services does Bioexcel provide?
Bioexcel supports European medical device clinical investigations, PMCF, retrospective studies, IVD performance studies, site feasibility, monitoring, data management, biostatistics and regulatory evidence documentation.
How does Bioexcel manage European programs?
Bioexcel combines suitable European local resources for study execution with centralized clinical strategy, project management, data management, statistics and medical writing.
Can Bioexcel support EU MDR and EU IVDR?
Yes. Bioexcel supports clinical evidence programs designed around EU MDR and EU IVDR requirements, subject to the specific product, classification and regulatory pathway.
Which European Country Is Best for Your Study?
There is no single best country for every medical device or IVD program. Country selection should consider:
- Target indication
- Disease prevalence
- Patient population
- Clinical standard of care
- Investigator expertise
- Site availability
- Device experience
- Study design
- Recruitment requirements
- Ethics process
- Regulatory pathway
- Data privacy
- Comparator availability
- Budget
- Timeline
- Language
| Factor | Country A | Country B | Country C |
|---|---|---|---|
| Patient availability | High | Medium | High |
| Site expertise | High | High | Medium |
| Expected timeline | Medium | Fast | Medium |
| Budget | Medium | Higher | Lower |
| Study suitability | High | High | Medium |
Can Bioexcel Help Select the Best European Country for a Study?
Yes. Bioexcel can compare candidate European countries based on patient or specimen availability, site expertise, regulatory and ethics considerations, operational timelines, cost and study-specific suitability.
Find Sites That Can Actually Deliver the Evidence
Bioexcel site feasibility may assess:
Clinical Expertise
- Relevant specialty
- Device experience
- Procedure expertise
- IVD experience
- Research background
Recruitment
- Monthly patient volume
- Eligibility pool
- Competing studies
- Follow-up potential
Infrastructure
- Cath lab
- Operating theatre
- Imaging
- Laboratory
- Sample processing
- Sample storage
- Research staff
Operations
- Ethics pathway
- Contracts
- Budget
- Monitoring access
- Source-data access
- Data privacy processes
Can Bioexcel Identify European Hospitals and Investigators?
Yes. Bioexcel can support European site and investigator feasibility based on the device or IVD, indication, patient or specimen requirements, investigator expertise, site infrastructure and expected study timelines.
Already Have a European Site?
Where the sponsor has already identified a hospital or investigator, Bioexcel can support functions such as:
- Feasibility confirmation
- Study start-up
- Ethics coordination
- Protocol implementation
- Site initiation
- Monitoring
- Data management
- Biostatistics
- Clinical reporting
- Project management
Can Bioexcel Manage a European Site Selected by the Sponsor?
Yes. Bioexcel can provide operational, monitoring, data, statistical and reporting support for sponsor-selected European sites depending on the required scope and local arrangements.
One European Site May Be Enough
A single-site model may be appropriate for:
- Specialized devices
- Targeted PMCF
- Small prospective studies
- Layperson studies
- Certain IVD performance programs
- Sponsor-owned site relationships
Site Should Be Selected Based On
- Patient/sample availability
- Investigator expertise
- Recruitment potential
- Infrastructure
- Study timelines
When Recruitment or Diversity Requires Multiple Sites
Multi-site studies may be useful where:
- Sample size is larger
- Recruitment is difficult
- Broader population representation is required
- Multiple clinical practice settings are important
- Rare clinical conditions are involved
Bioexcel can support centralized study management across participating sites.
Medical Device Clinical Investigations in Europe
Bioexcel supports:
Scope
- Clinical strategy
- CIP / protocol
- Site feasibility
- Investigator identification
- Study start-up
- Monitoring
- EDC
- Data management
- Statistics
- Clinical Investigation Report
Can Bioexcel Support EU MDR Clinical Investigations in Europe?
Yes. Bioexcel supports European medical device clinical investigations from study design and site feasibility through local execution, monitoring, data management, biostatistics and final clinical reporting.
PMCF Studies Across Europe
Bioexcel supports European:
Potential Objectives
- Long-term safety
- Device performance
- Revision
- Reintervention
- Clinical benefit
- Rare complications
- Device durability
Can Bioexcel Conduct PMCF in Europe?
Yes. Bioexcel supports European PMCF programs through suitable sites and local operational resources combined with centralized data, statistics, medical writing and clinical evaluation support.
Use Existing European Hospital Records Where Appropriate
European retrospective PMCF may be suitable where:
- The device has historical use
- Patient records exist
- Long-term follow-up is available
- Ethics and privacy requirements can be met
- The available data address the PMCF objective
Key Considerations
- GDPR
- Local privacy law
- Ethics requirements
- Data minimization
- Pseudonymization
- Source-data access
- Cross-border data flow
- Hospital governance
Can Bioexcel Support Retrospective PMCF in Europe?
Yes. Bioexcel can support European retrospective PMCF using suitable hospital records, subject to applicable ethics, privacy, data-access and institutional requirements.
EU IVDR Clinical Performance Studies
Bioexcel supports IVD programs involving:
- Prospective participants
- Archived samples
- Fresh specimens
- Comparator methods
- Reference testing
- Index-device testing
- Layperson studies
- Self-testing
- Data management
- IVD statistics
Can Bioexcel Conduct IVD Clinical Performance Studies in Europe?
Yes. Bioexcel supports European IVD clinical performance programs using suitable clinical sites, laboratories, participant populations and specimen sources, combined with centralized data management, statistics and reporting.
Clinical Samples, Biobanks & Reference Laboratories
Bioexcel can assess feasibility for:
- Serum
- Plasma
- Whole blood
- Urine
- Swabs
- Stool
- Other assay-specific specimens
Potential Cohorts
European Comparator & Reference Laboratory Coordination
Potential methods may include:
- PCR
- RT-PCR
- ELISA
- Culture
- LC-MS/MS
- GC-MS
- Laboratory analyzer methods
- Other justified reference methods
The comparator strategy should be selected according to the diagnostic claim and study design.
Intended-User Evidence in Europe
Bioexcel can support European studies assessing:
- IFU comprehension
- Device preparation
- Sample collection
- Device operation
- Result reading
- Result interpretation
- Invalid-result handling
- User error
- Questionnaire responses
Can Bioexcel Conduct Layperson IVD Studies in Europe?
Yes. Bioexcel can support European layperson and self-testing studies involving intended users, including participant recruitment, usability/performance assessments, data management, statistics and final reporting.
Local Clinical Monitoring With Central Oversight
Bioexcel can coordinate monitoring through appropriate European resources.
Potential Monitoring Activities
- Site initiation
- Interim visits
- Remote monitoring
- Source-data review
- Consent review
- Protocol compliance
- Safety review
- Device accountability
- Query follow-up
- Close-out
Central Bioexcel Oversight
- Enrollment
- Site performance
- Monitoring findings
- Protocol deviations
- Safety
- Queries
- Timelines
Does Bioexcel Provide Clinical Monitoring in Europe?
Yes. Bioexcel can coordinate European clinical monitoring through suitable local resources with centralized project oversight, depending on study requirements and country-specific operational arrangements.
Build the Data Flow Before the Study Starts
European clinical programs should define:
- What personal data are collected
- Where data are stored
- Who can access the data
- Whether data are pseudonymized
- Whether data cross borders
- Controller / processor roles
- Data retention
- Security controls
- Contractual responsibilities
Do not position Bioexcel website content as legal advice. Study-specific GDPR responsibilities should be reviewed with appropriate privacy/legal stakeholders.
Can European Study Data Be Managed Centrally?
Potentially yes. Centralized EDC, clinical data management, biostatistics and medical writing can support European studies when the data flow complies with applicable privacy, contractual, security and regulatory requirements.
European Study Execution With One Central Data Model
- Data Management Plan
- CRF/eCRF
- EDC
- User management
- Edit checks
- Queries
- Data review
- Reconciliation
- Database lock
- Data exports
Central Biometrics for European Clinical Programs
- Sample size
- Endpoint strategy
- SAP
- Safety analysis
- Performance analysis
- Time-to-event analysis
- IVD sensitivity/specificity
- PPA/NPA
- Tables/listings/figures
European Study Data to Regulatory Documentation
- CIP
- Protocol
- CPSP
- ICF/PIS content
- CIR
- CPSR
- PMCF Evaluation Report
- CER
- Regulatory response
European Data Should Feed the Regulatory Evidence Strategy
Clinical data generated in Europe may support:
When the European Study Is Triggered by a Notified Body Finding
A finding may identify:
- Insufficient long-term evidence
- Missing population data
- Inadequate PMCF
- Weak clinical benefit evidence
- Insufficient device-specific data
Local Execution + Central Clinical Evidence Expertise
European Local Activities
- Hospitals
- Investigators
- Ethics/regulatory coordination
- Participant recruitment
- Clinical procedures
- Local monitoring
- Sample collection
- Reference laboratories
Bioexcel Central Functions
- Clinical strategy
- Study design
- Project management
- EDC
- Data management
- Biostatistics
- Medical writing
- CER / PMCF
- Regulatory evidence
= One Coordinated MedTech Program
European Support Through the Bioexcel Network
Bioexcel's European delivery capabilities are supported through ECLEVAR, our European sister organization, providing access to local MedTech expertise and operational support for European clinical and regulatory programs.
- Local MedTech expertise
- Clinical operations coordination
- European site access
- Investigator engagement
- Monitoring support
- Regulatory/ethics coordination
- Sponsor communication
Bioexcel — Clinical Strategy, Data, Statistics, Medical Writing, CER / PMCF, Project Oversight
ECLEVAR / Europe — Local Clinical Operations, Sites, Investigators, Monitoring, Regional Support
Integrated Sponsor Delivery
How Does Bioexcel Deliver European Studies?
Bioexcel combines centralized clinical strategy, data, statistics and regulatory evidence functions with appropriate European local resources for site execution, investigator coordination, monitoring and other country-specific activities.
European Clinical Programs Across Medical Technologies
Cardiovascular & Structural Heart
Orthopedics & Spine
Surgical Robotics
Urology
IVD
Digital Health & AI
Flexible Study Models
Model 1 — Full-Service European Program
Bioexcel coordinates strategy, sites, execution, data and reporting.
Model 2 — One European Site
Suitable for targeted studies with adequate recruitment.
Model 3 — Sponsor-Selected Site
Sponsor provides site; Bioexcel provides agreed operational functions.
Model 4 — Functional Support
Examples: monitoring only, data management, statistics, medical writing, regulatory evidence.
Model 5 — Europe + India Hybrid Delivery
European clinical activities combined with centralized Bioexcel functions.
One Program Can Use Different Geographies for Different Evidence Needs
India
- Larger patient access
- Selected procedures
- Retrospective records
- IVD samples
- Central operations
Europe
- European population
- PMCF
- EU site data
- Layperson studies
- Local intended-use evidence
↓ One Central Evidence Strategy
The appropriate model should be based on regulatory relevance and scientific justification, not cost alone.
Why MedTech Sponsors Use Bioexcel for European Programs
Medical Device & IVD Focus
Programs are designed around MedTech evidence questions.
Local + Central Delivery
Local European clinical activities can be connected to centralized specialist functions.
Regulatory Evidence Integration
Study outcomes are designed to support CER, PMCF, PER and related evidence.
Flexible Scope
One site, multiple sites, full-service or functional support.
India + Europe Model
Sponsors can use different delivery locations for different project functions where appropriate.
Remediation Capability
A European study can be designed specifically to close an identified clinical evidence gap.
European Evidence Programs in Practice
European IVD Performance Study
Requirement: Clinical performance + intended-user evaluation
Bioexcel Role: Feasibility, site/lab coordination, data, statistics and reporting
European PMCF
Requirement: Post-market evidence in European clinical practice
Study Model: Prospective PMCF
European Archived-Sample Program
Requirement: Characterized positive/negative specimens
Model: Retrospective IVD performance study
Notified Body Evidence Gap
Requirement: Additional device-specific clinical evidence
Approach: Targeted European study
Frequently Asked Questions About Medical Device Clinical Research in Europe
Bioexcel supports European medical device clinical evidence programs through appropriate local clinical resources combined with centralized clinical, data, statistical and regulatory support.
Bioexcel connects European clinical execution with centralized MedTech clinical, data and regulatory expertise.